1.6000
+0.0800
+(5.26%)
At close: April 17 at 4:00:00 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | 1 |
| Avg. Estimate | -1.07 | -0.9 | -2.68 | -1.88 |
| Low Estimate | -1.07 | -0.9 | -2.68 | -1.88 |
| High Estimate | -1.07 | -0.9 | -2.68 | -1.88 |
| Year Ago EPS | -1.13 | -1.09 | 0.19 | -2.68 |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | 1 |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | -- | 0.00% | 0.00% | 0.00% |
Earnings History
| Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|---|
| EPS Est. | -1.2 | -0.97 | -1.01 | -1.05 |
| EPS Actual | -1.13 | -1.09 | 2.97 | -0.56 |
| Difference | 0.07 | -0.12 | 3.98 | 0.49 |
| Surprise % | 5.83% | -12.37% | 394.06% | 46.67% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -1.07 | -0.9 | -2.68 | -1.88 |
| 7 Days Ago | -1.07 | -0.9 | -2.68 | -1.08 |
| 30 Days Ago | -1.07 | -0.9 | -2.68 | -1.08 |
| 60 Days Ago | -1.07 | -0.9 | -2.68 | -1.08 |
| 90 Days Ago | -1.07 | -0.9 | -2.68 | -1.08 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | 1 | 1 |
| Down Last 30 Days | -- | -- | 1 | 1 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| NERV | 5.31% | 17.43% | -1,510.53% | 29.85% |
| S&P 500 | 6.92% | 5.09% | 8.78% | 14.15% |
Upgrades & Downgrades
| Reiterates | HC Wainwright & Co.: Neutral to Neutral | 2/26/2025 |
| Reiterates | HC Wainwright & Co.: Neutral to Neutral | 11/6/2024 |
| Maintains | HC Wainwright & Co.: Neutral to Neutral | 8/7/2024 |
| Maintains | HC Wainwright & Co.: Neutral to Neutral | 5/2/2024 |
| Reiterates | HC Wainwright & Co.: Neutral to Neutral | 2/27/2024 |
| Maintains | HC Wainwright & Co.: Neutral to Neutral | 8/2/2023 |
Related Tickers
KZR Kezar Life Sciences, Inc.
4.1600
+2.46%
EPIX ESSA Pharma Inc.
1.7900
+1.13%
HLVX HilleVax, Inc.
1.6900
+2.42%
IPSC Century Therapeutics, Inc.
0.5437
+8.74%
LVTX LAVA Therapeutics N.V.
1.3100
+6.50%
IKNA Ikena Oncology, Inc.
1.1100
0.00%
SPRO Spero Therapeutics, Inc.
0.7542
+1.92%
ASMB Assembly Biosciences, Inc.
10.03
+0.25%
BOLT Bolt Biotherapeutics, Inc.
0.3500
+5.42%
GLTO Galecto, Inc.
2.4300
+2.10%